Non-invasive analysis of tumor mutation profiles and druggable mutations by sequencing of cell free DNA of Chinese metastatic breast cancer patients

Thoracic Cancer
Shunying LiLiang Jin

Abstract

Metastatic breast cancer (MBC) remains an incurable disease worldwide. Tumor gene mutations have evolved and led to drug resistance in the treatment course of MBC. However, data on the mutation profiles and druggable genomic alterations of MBC remain limited, particularly among Chinese patients. Our study aimed to depict the mutation profiles and identify druggable mutations in circulating tumor DNA (ctDNA) in Chinese MBC patients. Targeted deep sequencing of a 1021-gene panel was performed on 17 blood samples and 5 available tissue samples from 17 Chinese MBC patients. We identified 60 somatic mutations in 17 blood samples (sensitivity 100%). Somatic mutations were identified in the blood samples of all patients, and 41.18% (7/17) of patients harbored at least one druggable mutation. A high ctDNA level in plasma is associated with shorter progression-free survival. Targeted deep sequencing of cell free DNA is a highly sensitive, noninvasive method to depict tumor mutation profiles, identify druggable mutations in MBC, and predict patient outcome. Our study shed light on the utility of ctDNA as noninvasive "liquid biopsy" in the management of MBC.

References

Jan 19, 2010·Bioinformatics·Heng Li, Richard Durbin
Oct 19, 2010·Nucleic Acids Research·Simon A ForbesP Andrew Futreal
Jun 23, 2012·Nature·Matthew J EllisElaine R Mardis
Jun 23, 2012·Nature·Shantanu BanerjiMatthew Meyerson
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Feb 12, 2013·Nature Biotechnology·Kristian CibulskisGad Getz
Mar 15, 2013·The New England Journal of Medicine·Sarah-Jane DawsonNitzan Rosenfeld
Feb 8, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julia A BeaverBen Ho Park
Feb 21, 2014·Science Translational Medicine·Chetan BettegowdaLuis A Diaz
Mar 19, 2014·Nature Methods·Andrew RothSohrab P Shah
Apr 15, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takashi NakaokuTakashi Kohno
Apr 17, 2015·Science Translational Medicine·Nicholas McGranahanCharles Swanton
Apr 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fabrice AndréDennis Slamon
Apr 27, 2017·Nature·Christopher AbboshCharles Swanton
Dec 30, 2017·Journal of breast cancer·Zongbi Yi, Fei Ma
Jan 4, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel G StoverViktor A Adalsteinsson
May 20, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Oliver A ZillAmirAli Talasaz

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR
biopsies

Software Mentioned

R pheatmap
R
MuTeck
ggplot2
PyClone
GraphPad Prism
Contra

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.